Nutra Pharma Corp (NPHC) Other Non Operating Income (2010 - 2026)

Nutra Pharma has disclosed Other Non Operating Income across 17 years of filings, most recently posting $2305.0 for Q2 2026.

• In Q2 2026, Other Non Operating Income fell 95.69% year-over-year to $2305.0; the TTM figure through Jun 2026 stood at $142805.0 (down 16.74% YoY), while the FY2025 annual figure was $58750.0, down 43.21% from the prior year.
• Other Non Operating Income came in at $2305.0 for Q2 2026 at Nutra Pharma, down from $140500.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $140500.0 in Q1 2026 to a low of -$114000.0 in Q2 2022.
• Average Other Non Operating Income over 5 years is $15927.2, with a median of $5357.5 recorded in 2022.
• Year-over-year, Other Non Operating Income plunged 6747.23% in 2022 and jumped 3433.33% in 2024.
• Over 5 years, Other Non Operating Income stood at $75.0 in 2022, then sank by 2100.0% to -$1500.0 in 2023, then soared by 1300.0% to $18000.0 in 2024, then jumped by 197.37% to $53526.0 in 2025, then tumbled by 95.69% to $2305.0 in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $2305.0 in Q2 2026, $140500.0 in Q1 2026, and $53526.0 in Q2 2025.